Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors
Clinical trial NCT06150183 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06150183
- Sponsor
- BioNTech SE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2027-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.